Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 28;11(19):5752.
doi: 10.3390/jcm11195752.

Effects of Reminiscence Therapy on Cognition, Depression and Quality of Life in Elderly People with Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials

Davide Maria Cammisuli  1 , Gabriele Cipriani  2 , Emanuele Maria Giusti  3 , Gianluca Castelnuovo  1   3
Affiliations
Review

Effects of Reminiscence Therapy on Cognition, Depression and Quality of Life in Elderly People with Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials

Davide Maria Cammisuli et al. J Clin Med. .

Abstract

Background: Patients with Alzheimer's disease (AD) present with cognitive function deterioration, neuropsychiatric symptoms (NPS)-especially depression-and low quality of life (QoL). Management of AD remains difficult, especially in the elderly. Reminiscence therapy (RT) is a well-known cognitive rehabilitation intervention that can be adopted in nursing and residential care homes to restore autobiographical memory, ameliorate NPS, and improve the QoL of people with dementia. However, the evidence-based efficacy of RT for elderly patients with AD remains to be determined.

Methods: Here, we synthesized findings of randomized controlled trials (RCTs) exploring the effects of RT on cognition, depression, and QoL in elderly people with AD, according to the most recent PRISMA statement. We searched for RCTs in PubMed, Web of Science, and Cochrane Central Register of Controlled Trials, and in trial registries (i.e., clinicaltrials.gov and International Clinical Trials Registry Platform of the World Health Organization). Two review authors extracted data of interest, with cognition, depression, and QoL measures as outcomes.

Results: A total of five articles were included in the final analysis. Findings globally showed that RT, both administered in individual or group sessions at least once a week for 30-35 min over a period of 12 weeks, is effective in supporting global cognition, ameliorating depression, and improving specific aspects of the QoL in elderly people with AD.

Conclusions: RT has the potential to be a routine non-pharmacological therapy for elderly people with AD, thanks to its wider effects on the individual in terms of cognitive vitality and emotional status promotion, with positive implications for patient's daily life. Despite such evidences, caution should be used in findings' generalizability in relation to the paucity of existing RCTs with long-term follow-up.

Keywords: Alzheimer’s disease; aging; cognitive function; depression; quality of life; reminiscence therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The PRIMA flow diagram.
See this image and copyright information in PMC

References

    1. United Nations; Department of Economic and Social Affairs; Population Division . World Population Ageing 2019: Highlights (ST/ESA/SER.A/430) United Nations; New York, NY, USA: 2019. pp. 5–10.
    1. Sink K.M., Covinsky K.E., Barnes D.E., Newcomer R.J., Yaffe K. Caregiver characteristics are associated with neuropsychiatric symptoms of dementia. JAGS. 2006;54:796–803. doi: 10.1111/j.1532-5415.2006.00697.x. - DOI - PubMed
    1. Cammisuli D.M., Franzoni F., Scarfò G., Fusi J., Gesi M., Bonuccelli U., Daniele S., Castelnuovo G. What Does the Brain Have to Keep Working at Its Best? Resilience Mechanisms Such as Antioxidants and Brain/Cognitive Reserve for Counteracting Alzheimer’s Disease Degeneration. Biology. 2022;11:650. doi: 10.3390/biology11050650. - DOI - PMC - PubMed
    1. Freitas S., Simões M.R., Alves L., Santana I. Montreal cognitive assessment: Validation study for mild cognitive impairment and Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2013;27:37–43. doi: 10.1097/WAD.0b013e3182420bfe. - DOI - PubMed
    1. Folstein M.F., Folstein S.E., McHugh P.R. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12:189–198. doi: 10.1016/0022-3956(75)90026-6. - DOI - PubMed

LinkOut - more resources